Taiwan Primo Biotechnology Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Primo’s products and services include radioligand therapeutic agents, tumor‑molecular imaging diagnostics (such as PB01 / [¹⁸F]PSMA‑1007 for prostate cancer), and imaging‑platform plus manufacturing services supporting clinical trials. The company has als
Founded Year
2021
Unified Business No.
90712775
Status
Active
Number of Employees
0
Total Paid-in
Capital
584,760,228 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Primo Biotechnology Co., Ltd., headquartered in Taipei, focuses on the development and manufacturing of precision medicine and radioligand theranostics (RLT). The company is committed to leveraging molecular imaging and radiopharmaceutical technologies to improve cancer diagnostics and therapy, with the vision "Future in Precision."
